Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer

समान संसाधन

• Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer.
  द्वारा: Allevi, G, और अन्य
  प्रकाशित: (2013)
• Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients.
  द्वारा: Generali, D, और अन्य
  प्रकाशित: (2009)
• Down-regulation of phosphatidylinositol 3'-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer.
  द्वारा: Generali, D, और अन्य
  प्रकाशित: (2008)
• Molecular oncology and the neoadjuvant setting: the perfect blend for treatment personalization and clinical trial design.
  द्वारा: Generali, D, और अन्य
  प्रकाशित: (2011)
• Effect of primary letrozole (LET) vs letrozole plus metronomic cyclophosphamide (LET-CYC) on Treg infiltration in ER plus ve breast cancer.
  द्वारा: Fox, S, और अन्य
  प्रकाशित: (2006)